Apr 30 |
Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results
|
Feb 29 |
Earnings Scheduled For February 29, 2024
|
Feb 28 |
Preview: Akili's Earnings
|
Feb 27 |
PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
|
Feb 26 |
Gold Moves Lower; Pilgrim's Pride Earnings Top Views
|
Feb 26 |
Akili's ADHD device submitted for Japanese approval, stock rallies 130%
|
Feb 26 |
Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan
|
Feb 21 |
Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates
|
Jan 15 |
Akili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
|
Dec 29 |
Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years
|